VIEMED HEALTHCARE, INC.

For the period ended Dec 31, 2025. Filed Mar 4, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 4, 2026

VMD$8.95-2.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

VIEMED HEALTHCARE, INC.
(Registrant)
By:	/s/ Casey Hoyt
	Casey Hoyt
	Chief Executive Officer
By:	/s/ Trae Fitzgerald
	Trae Fitzgerald
	Chief Financial Officer

Date: March 4, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Page

W. Todd Zehnder
Signature	Title	Date
/s/ Casey Hoyt	Chief Executive Officer and Director	March 4, 2026
Casey Hoyt	(Principal Executive Officer)
/s/ Trae Fitzgerald	Chief Financial Officer	March 4, 2026
Trae Fitzgerald	(Principal Financial Officer and Accounting Officer)
/s/ W. Todd Zehnder	Chief Operating Officer and Director	March 4, 2026
/s/ Randy Dobbs	Chairman of the Board of Directors	March 4, 2026
Randy Dobbs
/s/ Dr. William Frazier	Director and Chief Medical Officer	March 4, 2026
Dr. William Frazier
/s/ Sabrina Heltz	Director	March 4, 2026
Sabrina Heltz
/s/ Nitin Kaushal	Director	March 4, 2026
Nitin Kaushal
/s/ Timothy Smokoff	Director	March 4, 2026
Timothy Smokoff

Page

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.